Prestige Consumer Healthcare Inc. Stock
There is an upward development for Prestige Consumer Healthcare Inc. compared to yesterday, with an increase of €1.00 (2.150%).
Currently there is a rather positive sentiment for Prestige Consumer Healthcare Inc. with 3 Buy predictions and 0 Sell predictions.
With a target price of 64 € there is a positive potential of 34.45% for Prestige Consumer Healthcare Inc. compared to the current price of 47.6 €.
Pros and Cons of Prestige Consumer Healthcare Inc. in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prestige Consumer Healthcare Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prestige Consumer Healthcare Inc. | 2.150% | -2.439% | -11.927% | -31.429% | -10.280% | -17.241% | 31.148% |
| Apollo Medical Holdings, Inc. | 0.850% | 8.333% | 13.592% | -19.863% | 10.377% | -34.270% | - |
| Petmed Express Inc | 2.580% | -3.343% | -11.521% | -26.778% | -31.878% | -86.455% | -92.926% |
| Suzuken Co Ltd | -1.250% | -1.840% | -3.614% | 28.000% | -2.439% | 28.000% | 3.226% |
Comments
Prestige Consumer Healthcare (NYSE:PBH) had its price target lowered by analysts at Oppenheimer Holdings, Inc. from $82.00 to $72.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare (NYSE:PBH) was upgraded by analysts at Sidoti from a "neutral" rating to a "buy" rating. They now have a $80.00 price target on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for PBH provided by MarketBeat